R.L. Gustofson — Endo Lab

article 2017

GnRH agonist administration prior to embryo transfer in freeze-all cycles of patients with endometriosis or aberrant endometrial integrin expression

Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2017.05.004

Prolonged gonadotrophin-releasing hormone agonist (GnRHa) administration before IVF with fresh embryo transfer to patients with endometriosis or aberrant endometrial integrin expression (-integrin) improves outcomes but may suppress ovarian…

article 2016

Prolonged administration of GnRH agonist (GnRHa) prior to embryo transfer (ET) in endometriosis (ENDO) and integrin (INT)negative patients: the impact of freeze-all cycles

·doi:10.1016/j.fertnstert.2016.07.775

article 2009

Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?

Fertility and sterility ·doi:10.1016/j.fertnstert.2008.12.023

ObjectiveTo determine whether endometrial expression of the integrin alpha(v)beta(3) vitronectin can predict which endometriosis patient subgroup will benefit from pre-IVF cycle prolonged GnRH agonist (GnRHa) therapy.DesignProspective rando…

article 2007

Does endometrial αvβ3 vitronectin (β3) expression in endometriosis (ENDO) patients predict enhanced outcomes after prolonged GnRH agonist (GnRHa) therapy prior to in vitro fertilization (IVF)?

·doi:10.1016/j.fertnstert.2007.07.440

review 2006

Endometriosis and the appendix: a case series and comprehensive review of the literature

Fertility and sterility ·doi:10.1016/j.fertnstert.2005.12.076

ObjectiveTo report the prevalence of appendiceal disease in women with chronic pelvic pain undergoing laparoscopy for possible endometriosis, summarize the literature, and more accurately estimate the prevalence of endometriosis of the appe…